| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/11/2004 | WO2003063864A3 Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 03/11/2004 | WO2003062247A3 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace) |
| 03/11/2004 | WO2003061768A3 Use of a compound inactivating the kinase a protein in a composition containing a cosmetically acceptable medium in order to lighten the skin |
| 03/11/2004 | WO2003059395A3 Antisense compounds directed against human csf-1 |
| 03/11/2004 | WO2003059352A3 Use of a novel class of drugs for the treatment of parasitic diseases |
| 03/11/2004 | WO2003059323A3 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 03/11/2004 | WO2003057201A3 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 03/11/2004 | WO2003053945A3 Urea derivatives and their use as vanilloid receptor antagonists |
| 03/11/2004 | WO2003051395A3 Edg-receptor agonist for the treatment of hypertension |
| 03/11/2004 | WO2003043614A3 Reversible proton pump inhibitors for the treatment of airway disorders |
| 03/11/2004 | WO2003041736A3 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 03/11/2004 | WO2003040337A3 Polyamide modulators of cox2 transcription |
| 03/11/2004 | WO2003035051A3 The use of proton sequestering agents in drug formulations |
| 03/11/2004 | WO2003034978A3 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 03/11/2004 | WO2003030813A3 Anti-irritating rosacea treatment |
| 03/11/2004 | WO2003028653A3 Sustained release pharmaceutical compositions |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003017925A3 Treatment of type i diabetes |
| 03/11/2004 | WO2003015690B1 Method for treating primary insomnia |
| 03/11/2004 | WO2003014316A3 Immunomodulatory compositions, formulations, and methods for use thereof |
| 03/11/2004 | WO2003011294A3 Mucin synthesis inhibitors |
| 03/11/2004 | WO2003009845A9 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/11/2004 | WO2003009809A3 Cancer treatment with gö6976 and its related compounds |
| 03/11/2004 | WO2003006608A3 Enhancement of transfection of dna into the liver |
| 03/11/2004 | WO2003002524A3 Urea derivatives with antiproteolytic activity |
| 03/11/2004 | WO2003002060A3 Method of treating malignancy associated hypercalcemia using active vitamin d analogues |
| 03/11/2004 | WO2003000695A8 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/11/2004 | WO2003000191A3 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002102743A9 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002083074A3 Methods for the treatment of hepatic disorders |
| 03/11/2004 | WO2002082462A3 Stabilization and terminal sterilization of phospholipid formulations |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040049072 RXR modulators with improved pharmacologic profile |
| 03/11/2004 | US20040049060 Process for the preparation of paclitaxel |
| 03/11/2004 | US20040049059 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040049045 Process for the crystallization of (r)-or (s)-lansoprazole |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049036 From diphenyl (4-(4-fluorophenyl)-6-isopropyl-2-(methyl-(methyl sulfonyl)amino)pyrimidin-5-ylmethyl)phosphine and tert-butyl-2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl) acetate; removal of tert-butyl group to form acid or salt |
| 03/11/2004 | US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents |
| 03/11/2004 | US20040049031 Method for the synthesis of quinoline derivatives |
| 03/11/2004 | US20040049023 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty |
| 03/11/2004 | US20040048934 Self-emulsifying drug delivery system |
| 03/11/2004 | US20040048933 Autonomic nerve regulating agent |
| 03/11/2004 | US20040048932 Anesthetic e.g., sevoflurane, enflurane, isoflurane, methoxyflurane, or desflurane, containing a Lewis acid inhibitor |
| 03/11/2004 | US20040048931 Modafinil pharmaceutical compositions |
| 03/11/2004 | US20040048930 Antiarrhythmic agents; myocardial infarction prophylaxis and treatment; angina pectoris treatment |
| 03/11/2004 | US20040048929 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 03/11/2004 | US20040048927 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 03/11/2004 | US20040048926 Higher scores in mental and psychomotor development; better problem solving skills |
| 03/11/2004 | US20040048925 Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives |
| 03/11/2004 | US20040048924 Ibuprofen composition |
| 03/11/2004 | US20040048923 N-retinoyl-substituted cysteic, cysteinesulfinic, or homocysteic acids, esters or amides or sodium salts; increasing drug solubility |
| 03/11/2004 | US20040048922 Allomorph of isomer Z hydrochloride of alkylaminofurane derivative |
| 03/11/2004 | US20040048920 2-(p-(1-hydrocarbylsulfonylalkyl)phenyl)-1,1,1,3,3,3-hexafluoro-2-propanol derivatives; treating atherosclerosis, dyslipidemia, diabetes, Alzheimers disease, and Niemann-Pick disease. |
| 03/11/2004 | US20040048919 Related to premenstrual syndrome, premenstrual dysphoric disorder, perimenopause, menopause, or side effects of hormonal contraceptives; combination of polyunsaturated fatty acid and tocopherol derivative, most of which is not alpha |
| 03/11/2004 | US20040048918 Kamebanin, kamebacetal A, kamebakaurin, and exisanin A; inhibiting the production of nitric oxide, prostaglandin, and TNF-a, through the suppression of NF-k B activity. |
| 03/11/2004 | US20040048917 New use of compounds as antibacterial agents |
| 03/11/2004 | US20040048914 Treating rocaceo with a combination of a dicarboxylic acid (especially azelaic acid) and an antimicrobial (especially metronidazole) |
| 03/11/2004 | US20040048913 Substituted biaryl amides as C5a receptor modulators |
| 03/11/2004 | US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/11/2004 | US20040048911 Angiotensin II antagonists for treating cardiovascular disorders, hypertension, congestive heart failure and glaucoma. |
| 03/11/2004 | US20040048908 E.g., 3-(5-(3,4-dichlorophenyl)- 4-isoxazolyl)propan-1-ol; prophylaxis or treatment of diabetes, impaired glucose tolerance or diabetic complications |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048906 Synergistic combinations of amlodipine and atorvastatin used to treat angina pectoris, atherosclerosis, combined hypertension and hyperlipidemia and to treat subjects with symptoms of cardiac risk |
| 03/11/2004 | US20040048905 Therapeutic combination of amlodipine and benazepril |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048902 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 03/11/2004 | US20040048901 Increased water solubility and bioabsorption; treatment of CNS disorders such as depression and emesis |
| 03/11/2004 | US20040048900 Nicotine and/or nicotine agonists for the treatment of general anesthetic effects and side effects |
| 03/11/2004 | US20040048899 Antidiabetic agents suitable for large scale milling. |
| 03/11/2004 | US20040048898 Benzimidazole compound crystal |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048896 Treating gastric acid disorders by orally administering a proton pump inhibitor and a mixture of buffers |
| 03/11/2004 | US20040048894 Compounds which mimic the chemical and biological properties of discodermolide |
| 03/11/2004 | US20040048892 Treatment of diseases with adamantane derivatives |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048890 E.g., montelukast sodium and pseudoephedrine; treatment of allergic rhinitis or asthma |
| 03/11/2004 | US20040048889 Use of non-competitive and selective glur5 antagonists as gultamate receptor modulating compounds |
| 03/11/2004 | US20040048888 1,6-naphthyridineurea derivatives; treating excessive or undesirable angiogenesis and/or Tie2 receptor activity |
| 03/11/2004 | US20040048887 Respiratory disorders, particularly inhalants for asthma or COPD |
| 03/11/2004 | US20040048886 Respiratory disorders, particularly inhalants for asthma or COPD |
| 03/11/2004 | US20040048885 Imidazo[1,2,-A]pyridine ether compounds as ion channel modulators |
| 03/11/2004 | US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc. |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048881 Quinazoline derivatives with anti-tumour activity |
| 03/11/2004 | US20040048877 Pharmaceutical compositions containing flibanserin |
| 03/11/2004 | US20040048876 Ziprasidone composition and synthetic controls |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048874 New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
| 03/11/2004 | US20040048873 Pyrimidine compounds |
| 03/11/2004 | US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics. |
| 03/11/2004 | US20040048871 Use of high dose intravenous methotrexate, with leucovorin rescue, to treat early multiple sclerosis and other diseases of the central nervous system |
| 03/11/2004 | US20040048870 Composition for the prevention and treatment of migraine headaches |
| 03/11/2004 | US20040048869 Dopamine D4 receptor antagonist with antidepressant or anxiolytic agent. |